510(k) Report

510(k) · Cleared

Cleared

FM-02 Bone Graft Substitute

K102545510(k) SpecialCleared Oct 27, 201054-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Orthovita, Inc. · MQV Filler, Bone Void, Calcium Compound

Cleared on Oct 27, 2010 as substantially equivalent to K072184 (Orthovita, Inc., 2007) and 2 other predicates after a 54-day review. Its family tree reaches back 7 generations to 1996. 2 later devices descend from it.

Decided
Oct 27, 2010
Review
54 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
3

Its longest line of descent runs back 7 generations to K960978 (1996). 21 ancestors in all. 2 later devices descend from it, 1 citing it directly.

  1. Root · 7 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 6 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 5 generations backK021336 Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC · 2002
  4. 4 generations backK052494 Novabone-Bioactive Synthetic GraftNovabone Products, LLC · 2005
  5. 3 generations backK072184 Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc. · 2007
  6. 2 generations backK081439 Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc. · 2008
  7. 1 generation backK083033 Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister…Orthovita, Inc. · 2008
  8. This deviceK102545 FM-02 Bone Graft SubstituteOrthovita, Inc. · 2010
  9. Descendant · cites it directly · 1 of its ownK242280 Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip, Vitoss®…Stryker Spine · 2024
  10. Descendant · 2 generations on · 0 of its ownK261008 Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss®…Stryker Spine · 2026

Most influential descendants

Showing 2 of 2 · See all
  • K242280Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip, Vitoss® BiModal Bioactive…Stryker Spine · 2024 · cites it directly1descendant
  • K261008Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss® BiModal Bioactive…Stryker Spine · 2026 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−6K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−5K021336Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC2002—
−4K052494Novabone-Bioactive Synthetic GraftNovabone Products, LLC2005—
−3K072184Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc.2007—
−2K081439Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc.2008—
−1K083033Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister, Foam &…Orthovita, Inc.2008—
0 (this device)K102545FM-02 Bone Graft SubstituteOrthovita, Inc.2010—
+1K242280Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip, Vitoss® BiModal…Stryker Spine2024—
+2K261008Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss® BiModal…Stryker Spine2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200010
200120
200210
200340
200410
200520
200610
200710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
202610
FIG. 1 — Lineage of K102545, 1996–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K072184Vitoss Bioactive Foam Bone Graft Substitute
Summary page 1
…ation Number: 888.3045 Device Class: Class 11 Product Code: MQV 3. Predicate Device(s) Vitoss Bioactive Foam Bone Graft Substitute (K072184) Vitoss Bioactive Foam Bone Graft Substitute STRIP and PACK (K08 1439) Vitoss Bioactive Foam Bone Graft Substitute STRIP and PACK…
Orthovita, Inc.2007—
*K081439Vitoss Bioactive Foam Pack Bone Graft Substitute
Summary page 1
…Product Code: MQV 3. Predicate Device(s) Vitoss Bioactive Foam Bone Graft Substitute (K072184) Vitoss Bioactive Foam Bone Graft Substitute STRIP and PACK (K08 1439) Vitoss Bioactive Foam Bone Graft Substitute STRIP and PACK (K083033) 4. Device Description FM-02 Bone Graft Substitute is a res…
Orthovita, Inc.2008—
*K083033Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister, Foam & Bioactive…
Summary page 1
…ve Foam Bone Graft Substitute (K072184) Vitoss Bioactive Foam Bone Graft Substitute STRIP and PACK (K08 1439) Vitoss Bioactive Foam Bone Graft Substitute STRIP and PACK (K083033) 4. Device Description FM-02 Bone Graft Substitute is a resorbable porous bone void filler for the repair of bony defects. It is…
Orthovita, Inc.2008—

Also cleared against K072184: 3 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K242280Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip, Vitoss® BiModal Bioactive…Stryker Spine20241

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 4 companies; a new generation was cleared every 2.0 years on median.
  • 2 of the 21 ancestors have a recall of any class.
  • Of its descendants, K242280 (Stryker Spine, 2024) has gone furthest, with 1 descendant of its own.
  • 3 other devices also cite its predicate K072184.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

FM-02 Bone Graft Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. FM-02 is indicated for use in the treatment of surgically created osseous defects or osseous defects created from traumatic injury to the bone.

FM-02 Bone Graft Substitute is intended to be used for filling bony voids or gaps of the skeletal system (i.e., the extremities, pelvis and posterolateral spine), and may be combined with saline, autogenous blood, and/or bone marrow. Following placement in the bony void or gap, the scaffold resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K102545: FM-02 Bone Graft Substitute.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K102545

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026